نتائج البحث

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Journal for immunotherapy of cancer, vol 7, iss 1
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: CD4-Positive T-Lymphocytes, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, B7-H1 Antigen, 0302 clinical medicine, Programmed Death-1 (PD-1), Transforming Growth Factor beta, Receptors, Monoclonal, Immunology and Allergy, Cytotoxic T cell, Programmed Death-1, T cell receptor (TCR) signaling, Humanized, Cancer, biology, CD28, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, Metastatic breast cancer, 3. Good health, medicine.anatomical_structure, Antigen, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, Adult, medicine.medical_specialty, T cell, CD3, Clinical Trials and Supportive Activities, Immunology, Receptors, Antigen, T-Cell, Short Report, Breast Neoplasms, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Antibodies, Young Adult, 03 medical and health sciences, Clinical Research, Internal medicine, Breast Cancer, medicine, Humans, Aged, Pharmacology, Radiotherapy, business.industry, T-Cell, medicine.disease, Brain Disorders, Blockade, 030104 developmental biology, biology.protein, business, CD8

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0de02b3e707cde82b05a73fb8b56c4Test
http://link.springer.com/article/10.1186/s40425-019-0633-xTest

6

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma

المؤلفون: Benjamin Newell Voorhies, Jordan P. McPherson, Daniel S. Sageser, Siwen Hu-Lieskovan, Jocelyn Wallentine, Umang Swami, Kenneth F. Grossmann, Rebecca Pokorny, Zachary Tolman, Benjamin Haaland, Carolyn Luckett

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Immunology, Programmed Cell Death 1 Receptor, Pembrolizumab, Disease, Risk Assessment, law.invention, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, melanoma, Immunology and Allergy, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Immune Checkpoint Inhibitors, RC254-282, Response Evaluation Criteria in Solid Tumors, Aged, Pharmacology, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, business.industry, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Survival Analysis, Discontinuation, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Nivolumab, business, Decision Making, Shared, Cohort study, Brain metastasis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0f7bc3683ae0280f6ab07f3d20dc7eTest
http://europepmc.org/articles/PMC7843310Test

7

Efficacy and immune-related adverse event associations in avelumab-treated patients

المؤلفون: Isabell Speit, Sandra P. D'Angelo, Karen Kelly, Marcis Bajars, Vijay Kasturi, Arun Rajan, Juliane Manitz, Manish R. Patel, James L. Gulley, Andrea B. Apolo, John Warth

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, medicine.medical_treatment, Immunology, Improved survival, biostatistics, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, medicine, Immunology and Allergy, Humans, Adverse effect, RC254-282, Aged, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, business.industry, Proportional hazards model, Confounding, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3df9809ae6ddcc1d0ceaf44360b85cTest
https://jitc.bmj.com/content/8/2/e001427.fullTest

8

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

المؤلفون: Gaurav Chatterjee, Hasmukh Jain, Nilesh Deshpande, Nikhil Patkar, Gaurav Narula, Manju Sengar, Navin Khattry, Sitaram Ghogale, Bhausaheb Bagal, Shripad Banavali, Y. Badrinath, Harshini Sriram, Papagudi Ganesan Subramanian, Twinkle Khanka, Sumeet Gujral, Devasis Panda, Prashant Tembhare

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, Cancer Research, Neoplasm, Residual, medicine.medical_treatment, Disease, CD38, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Gastroenterology, receptors, antigen, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, hematologic neoplasms, Child, RC254-282, Membrane Glycoproteins, medicine.diagnostic_test, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Flow Cytometry, Prognosis, Survival Rate, medicine.anatomical_structure, Oncology, Child, Preschool, translational medical research, Molecular Medicine, Female, immunotherapy, Adult, medicine.medical_specialty, Adolescent, medicine.drug_class, T cell, Immunology, Monoclonal antibody, Flow cytometry, Young Adult, Internal medicine, medicine, Biomarkers, Tumor, Humans, Pharmacology, Chemotherapy, business.industry, Infant, Basic Tumor Immunology, Immunotherapy, ADP-ribosyl Cyclase 1, Drug Resistance, Neoplasm, antigens, neoplasm, Hematological neoplasm, Neoplasm Recurrence, Local, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6c2c209906107c5f4e8fa5c061452cTest
https://jitc.bmj.com/content/8Test/1/e000630.full

9

Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

المؤلفون: Makoto Ueno, Motonobu Osada, Do Youn Oh, Shunsuke Kondo, Hye Jin Choi, Masafumi Ikeda, Changhoon Yoo, Christoph Helwig, Masatoshi Kudo, Isabelle Dussault, Li-Tzong Chen

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Immunoconjugates, medicine.medical_treatment, Gastroenterology, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Transforming Growth Factor beta, Maculopapular rash, Clinical endpoint, Immunology and Allergy, RC254-282, Clinical/Translational Cancer Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Rash, Progression-Free Survival, Biliary Tract Neoplasms, Oncology, Tolerability, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, medicine.symptom, Signal Transduction, Adult, medicine.medical_specialty, Recombinant Fusion Proteins, Immunology, programmed cell death 1 receptor, gastrointestinal neoplasms, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, tumor microenvironment, Adverse effect, Aged, Pharmacology, Chemotherapy, Septic shock, business.industry, Receptor, Transforming Growth Factor-beta Type II, medicine.disease, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87733229294434fe031dbd7064b6ffd5Test
https://jitc.bmj.com/content/8Test/1/e000564.full

10

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

المؤلفون: Haiying Sun, Marcus O. Butler, Sunil Sharma, Jason E. Faris, Hongqian Wu, Jennifer Marie Mataraza, Andrea Varga, Todd M. Bauer, Jan H.M. Schellens, Antonio P. Silva, Justin F. Gainor, Chia-Chi Lin, Scott Cameron, Matthew H. Taylor, Aung Naing, Hans Gelderblom, Maria Ochoa de Olza, Patrick M. Forde

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, 8(1). BMJ PUBLISHING GROUP
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Gastroenterology, 0302 clinical medicine, Renal cell carcinoma, Neoplasms, Immunology and Allergy, Medicine, Tissue Distribution, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, education.field_of_study, clinical trials as topic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Sarcoma, immunotherapy, medicine.symptom, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Nausea, Immunology, Population, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, 03 medical and health sciences, Young Adult, Pharmacokinetics, Internal medicine, Anal cancer, Humans, Adverse effect, education, Aged, Pharmacology, Dose-Response Relationship, Drug, business.industry, Immunotherapy, medicine.disease, 030104 developmental biology, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91537c2bd5448479962ac708483963cTest
https://jitc.bmj.com/content/8Test/1/e000530.full

تنقيح النتائج